115 related articles for article (PubMed ID: 10940799)
1. Pleural SC5b-9: a test for identifying complicated parapneumonic effusions.
Vives M; Porcel JM; Gázquez I; Pérez B; Rubio M
Respiration; 2000; 67(4):433-8. PubMed ID: 10940799
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of pleural complement activation products in differentiating tuberculosis and malignant effusions.
Porcel JM; Vives M; Gázquez I; Vicente de Vera MC; Pérez B; Rubio M
Int J Tuberc Lung Dis; 2000 Jan; 4(1):76-82. PubMed ID: 10654648
[TBL] [Abstract][Full Text] [Related]
3. Pleural SC5b-9 in differential diagnosis of tuberculous, malignant, and other effusions.
Hara N; Abe M; Inuzuka S; Kawarada Y; Shigematsu N
Chest; 1992 Oct; 102(4):1060-4. PubMed ID: 1395743
[TBL] [Abstract][Full Text] [Related]
4. SC5b-9 is the most sensitive marker in assessing disease activity in Brazilian SLE patients.
Chiu YY; Nisihara RM; Würzner R; Kirschfink M; de Messias-Reason IJ
J Investig Allergol Clin Immunol; 1998; 8(4):239-44. PubMed ID: 9777539
[TBL] [Abstract][Full Text] [Related]
5. Role of pleural fluid C-reactive protein concentration in discriminating uncomplicated parapneumonic pleural effusions from complicated parapneumonic effusion and empyema.
Chen SC; Chen W; Hsu WH; Yu YH; Shih CM
Lung; 2006; 184(3):141-5. PubMed ID: 16902838
[TBL] [Abstract][Full Text] [Related]
6. Complement components and their activation products in pleural fluid.
Salomaa ER; Viander M; Saaresranta T; Terho EO
Chest; 1998 Sep; 114(3):723-30. PubMed ID: 9743157
[TBL] [Abstract][Full Text] [Related]
7. Predictive Value of Pleural Cytology in the Diagnosis of Complicated Parapneumonic Effusions and Empyema Thoracis.
Ferguson J; Kazimir M; Gailey M; Moore F; Schott E
Pulm Med; 2020; 2020():7175451. PubMed ID: 32518695
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of complement activation product levels to detect infected pleural effusion in rats.
Peterson GE; Silva SS; Amantéa SL; Miorelli P; Sanches P; Kulczynski J; Roesch E; Fraga JC
Pediatr Pulmonol; 2017 Jun; 52(6):757-762. PubMed ID: 28474458
[TBL] [Abstract][Full Text] [Related]
9. Pleural fluid interleukin-8 and C-reactive protein for discriminating complicated non-purulent from uncomplicated parapneumonic effusions.
Porcel JM; Galindo C; Esquerda A; Trujillano J; Ruiz-González A; Falguera M; Vives M
Respirology; 2008 Jan; 13(1):58-62. PubMed ID: 18197912
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of complement activation between tuberculous and malignant pleuritis].
Hidaka K; Abe M; Tanaka T; Mitsuyama T; Hara N; Hara N
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Apr; 33(4):379-83. PubMed ID: 7791265
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha in pleural fluid: a marker of complicated parapneumonic effusions.
Porcel JM; Vives M; Esquerda A
Chest; 2004 Jan; 125(1):160-4. PubMed ID: 14718436
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase levels in the differentiation of parapneumonic pleural effusions.
Oikonomidi S; Kostikas K; Kalomenidis I; Tsilioni I; Daenas C; Gourgoulianis KI; Kiropoulos TS
Respiration; 2010; 80(4):285-91. PubMed ID: 20453486
[TBL] [Abstract][Full Text] [Related]
13. Residual pleural thickening is related to vascular endothelial growth factor levels in parapneumonic pleural effusions.
Papaioannou AI; Kostikas K; Tsopa P; Kiropoulos T; Tsilioni I; Oikonomidi S; Gerogianni I; Gourgoulianis KI
Respiration; 2010; 80(6):472-9. PubMed ID: 20029166
[TBL] [Abstract][Full Text] [Related]
14. Serum amyloid alpha in parapneumonic effusions.
Boultadakis V; Skouras V; Makris D; Damianaki A; Nikoulis DJ; Kiropoulos T; Oikonomidi S; Tsilioni I; Gourgoulianis K
Mediators Inflamm; 2011; 2011():237638. PubMed ID: 21876610
[TBL] [Abstract][Full Text] [Related]
15. A Simple Method for Differentiating Complicated Parapneumonic Effusion/Empyema from Parapneumonic Effusion Using the Split Pleura Sign and the Amount of Pleural Effusion on Thoracic CT.
Tsujimoto N; Saraya T; Light RW; Tsukahara Y; Koide T; Kurai D; Ishii H; Kimura H; Goto H; Takizawa H
PLoS One; 2015; 10(6):e0130141. PubMed ID: 26076488
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of complement activation fragments C3a and sC5b-9 for development of severe disease in patients with acute pancreatitis.
Gloor B; Stahel PF; Müller CA; Schmidt OI; Büchler MW; Uhl W
Scand J Gastroenterol; 2003 Oct; 38(10):1078-82. PubMed ID: 14621284
[TBL] [Abstract][Full Text] [Related]
17. Diagnostically significant variations in pleural fluid pH in loculated parapneumonic effusions.
Maskell NA; Gleeson FV; Darby M; Davies RJ
Chest; 2004 Dec; 126(6):2022-4. PubMed ID: 15596709
[TBL] [Abstract][Full Text] [Related]
18. Parapneumonic effusions and empyema.
Light RW
Clin Chest Med; 1985 Mar; 6(1):55-62. PubMed ID: 3847302
[TBL] [Abstract][Full Text] [Related]
19. Pleural-fluid myeloperoxidase in complicated and noncomplicated parapneumonic pleural effusions.
Alegre J; Jufresa J; Segura R; Ferrer A; Armadans L; Aleman C; Marti R; Ruiz E; Fernández de Sevilla T
Eur Respir J; 2002 Feb; 19(2):320-5. PubMed ID: 11866013
[TBL] [Abstract][Full Text] [Related]
20. Pleural fluid C-reactive protein contributes to the diagnosis and assessment of severity of parapneumonic effusions.
Porcel JM; Bielsa S; Esquerda A; Ruiz-González A; Falguera M
Eur J Intern Med; 2012 Jul; 23(5):447-50. PubMed ID: 22726374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
